Bolinger AA - Search Results

1

Design, synthesis, and pharmacological evaluations of pyrrolo[1,2-a]quinoxaline-based derivatives as potent and selective sirt6 activators.

Xu J, Shi S, Liu G, Xie X, Li J, Bolinger AA, Chen H, Zhang W, Shi PY, Liu H, Zhou J. Xu J, et al. Among authors: bolinger aa. Eur J Med Chem. 2023 Jan 15;246:114998. doi: 10.1016/j.ejmech.2022.114998. Epub 2022 Dec 6. Eur J Med Chem. 2023. PMID: 36508969 Free PMC article.

2

Target-Based Small Molecule Drug Discovery Towards Novel Therapeutics for Inflammatory Bowel Diseases.

Li Y, Chen J, Bolinger AA, Chen H, Liu Z, Cong Y, Brasier AR, Pinchuk IV, Tian B, Zhou J. Li Y, et al. Among authors: bolinger aa. Inflamm Bowel Dis. 2021 Nov 15;27(Suppl 2):S38-S62. doi: 10.1093/ibd/izab190. Inflamm Bowel Dis. 2021. PMID: 34791293 Review.

3

Bromodomain-containing protein 4 (BRD4): a key player in inflammatory bowel disease and potential to inspire epigenetic therapeutics.

Ma Z, Bolinger AA, Zhou J, Tian B. Ma Z, et al. Among authors: bolinger aa. Expert Opin Ther Targets. 2023 Jan;27(1):1-7. doi: 10.1080/14728222.2023.2175317. Epub 2023 Feb 7. Expert Opin Ther Targets. 2023. PMID: 36710583 Free PMC article. Review.

4

Novel approaches to targeted protein degradation technologies in drug discovery.

Xue Y, Bolinger AA, Zhou J. Xue Y, et al. Among authors: bolinger aa. Expert Opin Drug Discov. 2023 Apr;18(4):467-483. doi: 10.1080/17460441.2023.2187777. Epub 2023 Mar 9. Expert Opin Drug Discov. 2023. PMID: 36895136 Free PMC article. Review.

5

Therapeutic potential of salicylamide derivatives for combating viral infections.

Xu J, Xue Y, Bolinger AA, Li J, Zhou M, Chen H, Li H, Zhou J. Xu J, et al. Among authors: bolinger aa. Med Res Rev. 2023 Jul;43(4):897-931. doi: 10.1002/med.21940. Epub 2023 Mar 10. Med Res Rev. 2023. PMID: 36905090 Free PMC article. Review.

6

Discovery of Novel Oleamide Analogues as Brain-Penetrant Positive Allosteric Serotonin 5-HT_2C Receptor and Dual 5-HT_2C/5-HT_2A Receptor Modulators.

Chen J, Garcia EJ, Merritt CR, Zamora JC, Bolinger AA, Pazdrak K, Stafford SJ, Mifflin RC, Wold EA, Wild CT, Chen H, Anastasio NC, Cunningham KA, Zhou J. Chen J, et al. Among authors: bolinger aa. J Med Chem. 2023 Jul 27;66(14):9992-10009. doi: 10.1021/acs.jmedchem.3c00908. Epub 2023 Jul 18. J Med Chem. 2023. PMID: 37462530 Free PMC article.

7

Exploring New Vista for Alzheimer's Disease Drug Targets (Part II).

Bolinger AA, Zhou J. Bolinger AA, et al. Curr Top Med Chem. 2023;23(13):1211-1213. doi: 10.2174/156802662313230626121232. Curr Top Med Chem. 2023. PMID: 37464550 Free PMC article. No abstract available.

8

Drug Discovery Targeting Nuclear Receptor Binding SET Domain Protein 2 (NSD2).

Ma Z, Bolinger AA, Chen H, Zhou J. Ma Z, et al. Among authors: bolinger aa. J Med Chem. 2023 Aug 24;66(16):10991-11026. doi: 10.1021/acs.jmedchem.3c00948. Epub 2023 Aug 14. J Med Chem. 2023. PMID: 37578463 Free PMC article. Review.

9

RIPTACs: A groundbreaking approach to drug discovery.

Ma Z, Bolinger AA, Zhou J. Ma Z, et al. Among authors: bolinger aa. Drug Discov Today. 2023 Nov;28(11):103774. doi: 10.1016/j.drudis.2023.103774. Epub 2023 Sep 19. Drug Discov Today. 2023. PMID: 37734702 Free PMC article. Review.

10

Highlights on Fluorine-containing Drugs Approved by U.S. FDA in 2023.

Ali S, Bolinger AA, Zhou J. Ali S, et al. Among authors: bolinger aa. Curr Top Med Chem. 2024;24(10):843-849. doi: 10.2174/0115680266300245240223070242. Curr Top Med Chem. 2024. PMID: 38445700 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Search Page

Filters